RAF MUTATION
Clinical trials for RAF MUTATION explained in plain language.
Never miss a new study
Get alerted when new RAF MUTATION trials appear
Sign up with your email to follow new studies for RAF MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer drug trial halted early after 29 patients
Disease control TerminatedThis early-phase trial tested a new drug, DCC-3084, alone or with other treatments, in people with advanced solid tumors linked to MAPK pathway mutations (like certain lung, pancreatic, or skin cancers). The study aimed to find safe doses and check if tumors shrank. It was termin…
Matched conditions: RAF MUTATION
Phase: PHASE1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated May 26, 2026 11:27 UTC
-
Targeted cancer drug shows promise but study halted early
Disease control TerminatedThis study tested a drug called tovorafenib in people aged 12 and older with advanced solid tumors that have specific genetic changes (MAPK pathway). The goal was to see if the drug could shrink tumors. The study was stopped early, but the results may help guide future treatments…
Matched conditions: RAF MUTATION
Phase: PHASE2 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC